Table 4.
Factors | Adjusted odds ratio (OR) | 95% CI | P-value |
---|---|---|---|
Gender | |||
Female | 1.06 | 1.02–1.10 | 0.006 |
Age | |||
15–19 years | Ref | ||
10–14 years | 1.06 | 0.99–1.13 | 0.076 |
5–9 years | 1.20 | 1.11–1.30 | <0.001 |
0–4 years | 1.08 | 1.01–1.15 | 0.029 |
Primary payer | |||
Public | Ref | ||
Private | 1.08 | 1.02–1.13 | 0.004 |
Self-pay | 1.05 | 0.89–1.23 | 0.591 |
Other | 0.96 | 0.85–1.08 | 0.467 |
Median household income per ZIP code | |||
1st quartile | Ref | ||
2nd quartile | 1.08 | 1.01–1.16 | 0.032 |
3rd quartile | 1.10 | 1.03–1.18 | 0.01 |
4th quartile | 1.07 | 1.00–1.15 | 0.05 |
Hospital location-teaching status | |||
Urban, teaching | Ref | ||
Urban, non-teaching | 1.12 | 0.96–1.31 | 0.16 |
Rural | 2.01 | 1.57–2.58 | <0.001 |
Hospital region | |||
Northeast | Ref | ||
Midwest | 1.22 | 1.09–1.36 | <0.001 |
South | 1.04 | 0.94–1.15 | 0.41 |
West | 0.94 | 0.85–1.05 | 0.298 |
Type of infection | |||
Upper respiratory infection | 1.07 | 0.97–1.18 | 0.165 |
Acute otitis media | 1.26 | 1.10–1.44 | 0.001 |
Bloodstream infection | 0.21 | 0.18–0.24 | <0.001 |
Viral infection | 1.82 | 1.55–2.15 | <0.001 |
Urinary tract infection | 0.44 | 0.39–0.50 | <0.001 |
Pneumonia | 0.27 | 0.22–0.32 | <0.001 |
Type of cancer | |||
ALL | 0.84 | 0.78–0.89 | <0.001 |
Bone cancer | 0.77 | 0.71–0.85 | <0.001 |
Central nervous system tumor | 0.99 | 0.92–1.07 | 0.787 |
AML | 0.40 | 0.36–0.45 | <0.001 |
Soft tissue sarcoma | 1.25 | 1.13–1.37 | <0.001 |
Neuroblastoma | 0.56 | 0.48–0.66 | <0.001 |
Hodgkin lymphoma | 1.66 | 1.45–1.91 | <0.001 |
Wilms tumor | 0.59 | 0.52–0.68 | <0.001 |
Non-Hodgkin lymphoma | 0.46 | 0.39–0.54 | <0.001 |
Ovarian or testicular tumor | 0.63 | 0.52–0.76 | <0.001 |
Controlled for Race; CI = Confidence Interval, ALL = Acute Lymphoblastic Leukemia; AML = Acute Myelogenous Leukemia; Type of Infection and Type of Cancer are presented as dichotomous variables